August 2015

New Indications

Enbrel (etanercept (rch)) is now also indicated in the treatment of adults with active (active disease is defined as a Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score of ≥ 4), nonradiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or MRI change who have had an inadequate response to NSAIDs.

As Neutrafluor 5000 Plus (sodium fluoride) delivers fluoride topically to teeth and is intended for erupted teeth in adults and children over the age of ten, the increased fluoride dose should not contribute to fluorosis provided it is not used in an unsupervised manner in children under ten years of age.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au